Open | - |
Close | - |
Volume / Avg. | 1.477K / 346.043K |
Day Range | - - - |
52 Wk Range | 3.360 - 70.000 |
Market Cap | $19.483M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | % |
Days to Cover | 3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of T2 Biosystems (NASDAQ: TTOO) through any online brokerage.
Other companies in T2 Biosystems’s space includes: Galecto (NASDAQ:GLTO), Lumos Pharma (NASDAQ:LUMO), NuCana (NASDAQ:NCNA), Indaptus Therapeutics (NASDAQ:INDP) and Tonix Pharmaceuticals (NASDAQ:TNXP).
The latest price target for T2 Biosystems (NASDAQ: TTOO) was reported by Alliance Global Partners on Thursday, July 13, 2023. The analyst firm set a price target for 0.07 expecting TTOO to fall to within 12 months (a possible -98.23% downside). 1 analyst firms have reported ratings in the last year.
The stock price for T2 Biosystems (NASDAQ: TTOO) is $3.95 last updated Today at March 19, 2024 at 8:55 AM EDT.
There are no upcoming dividends for T2 Biosystems.
T2 Biosystems’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for T2 Biosystems.
T2 Biosystems is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.